These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16018942

  • 21. [Treatment of gastrointestinal stromal tumor (GIST)--review of the literature and a case report].
    Geraci G, Li Volsi F, Pisello F, Sciumè C, Cajozzo M, Cavaleri C, Modica G.
    Ann Ital Chir; 2005; 76(4):377-80; discussion 381. PubMed ID: 16550875
    [Abstract] [Full Text] [Related]

  • 22. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Cohen MH, Farrell A, Justice R, Pazdur R.
    Oncologist; 2009 Feb; 14(2):174-80. PubMed ID: 19193781
    [Abstract] [Full Text] [Related]

  • 23. [Rectal stromal tumors: a clinicopathological study of 16 cases].
    Wan YL, Tang JQ, Liu P, Liu YC, Wang X, Wu T, Pan YS, Huang YT.
    Zhonghua Wai Ke Za Zhi; 2004 Aug 07; 42(15):897-900. PubMed ID: 15363247
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients].
    Bar-Sela G, Lev LM, Kuten A, Wollner M, Haim N.
    Harefuah; 2006 Jan 07; 145(1):2-7, 80. PubMed ID: 16450715
    [Abstract] [Full Text] [Related]

  • 25. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate.
    Steinert DM, Oyarzo M, Wang X, Choi H, Thall PF, Medeiros LJ, Raymond AK, Benjamin RS, Zhang W, Trent JC.
    Cancer; 2006 Apr 01; 106(7):1617-23. PubMed ID: 16518826
    [Abstract] [Full Text] [Related]

  • 26. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Benjamin RS, Blanke CD, Blay JY, Bonvalot S, Eisenberg B.
    Oncologist; 2006 Jan 01; 11(1):9-20. PubMed ID: 16401709
    [Abstract] [Full Text] [Related]

  • 27. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
    Bonvalot S, Eldweny H, Péchoux CL, Vanel D, Terrier P, Cavalcanti A, Robert C, Lassau N, Cesne AL.
    Ann Surg Oncol; 2006 Dec 01; 13(12):1596-603. PubMed ID: 16957966
    [Abstract] [Full Text] [Related]

  • 28. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB, Trivett M, Beshay V, Dobrovic A, Kovalenko S, Murray W, Lade S, Turner H, McArthur GA, Zalcberg J, Waring PM.
    Histopathology; 2006 Jul 01; 49(1):52-65. PubMed ID: 16842246
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Flushing revealing the recurrence of a rectal gastrointestinal stromal tumour. Efficacy of imatinib].
    Bouché O, Lagarde S, Guillou PJ, Ramaholimihaso F, Lubrano D, Diébold MD, Delattre JF, Nguyen TD, Cadiot G, Thiéfin G.
    Gastroenterol Clin Biol; 2006 Apr 01; 30(4):636-7. PubMed ID: 16733396
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.
    Med Sci Monit; 2007 Nov 01; 13(11):CR515-522. PubMed ID: 17968300
    [Abstract] [Full Text] [Related]

  • 36. [Imatinib in gastrointestinal stromal tumor treatment--results from University Hospital Centre Zagreb].
    Vrbanec D, Petricević B, Majerović M, Stern-Padovan R, Belev B, Skegro M, Herceg D, Plestina S, Dedić-Plavetić N, Jakić-Razumović J.
    Lijec Vjesn; 2006 Nov 01; 128(5-6):161-6. PubMed ID: 16910417
    [Abstract] [Full Text] [Related]

  • 37. [Clinical guidelines for the management of gastrointestinal stromal tumors].
    Lopez M, Comandone A, Adamo V, Apice G, Bearzi I, Bracci R, Carlini M, Carpano S, Condorelli S, Covello R, Cucchiara G, Di Filippo F, Doglietto GB, Ficorella C, Garofalo A, Gebbia N, Giuliani F, Massidda B, Messerini L, Palmirotta R, Tonelli F, Vidiri A.
    Clin Ter; 2006 Nov 01; 157(3):283-99. PubMed ID: 16900856
    [Abstract] [Full Text] [Related]

  • 38. Gastrointestinal stromal tumors: a contemporary review.
    Parfitt JR, Streutker CJ, Riddell RH, Driman DK.
    Pathol Res Pract; 2006 Nov 01; 202(12):837-47. PubMed ID: 17064855
    [Abstract] [Full Text] [Related]

  • 39. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
    Boruban C, Sencan O, Akmansu M, Atik ET, Ozbek S.
    Anticancer Drugs; 2007 Sep 01; 18(8):969-72. PubMed ID: 17667604
    [Abstract] [Full Text] [Related]

  • 40. Rectal leiomyosarcoma: report on two cases and a practical approach to differential diagnosis.
    Kourda N, Kourda J, Aouam J, Zaouche A, Ben Jilani SB, Zermani R.
    Pathologica; 2010 Oct 01; 102(5):417-9. PubMed ID: 21361124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.